Leflunomide: all 68 studies that test it
Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant PatientsRecruitingNCT07709013Phase 2
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic SyndromesRecruitingNCT06923488Phase 1/2
- Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine TumorRecruitingNCT06540937Phase 2
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerRecruitingNCT06454383Phase 1
- Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS MutationsRecruitingNCT06229340Phase 2
- Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting ConditionsNot yet recruitingNCT06228443Phase 1
- Leflunomide for Henoch-Schonlein PurpuraRecruitingNCT05937880Not applicable
- Leflunomide for Idiopathic Pulmonary Hemosiderosis in ChildrenRecruitingNCT05937191Phase 1/2
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementRecruitingNCT05789017Not applicable
- The Clinical Efficacy of Immunomodulators in RA PatientsRecruitingNCT05626348Phase 4
- Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic MalignanciesRecruitingNCT05443425Phase 1
- New Clinical End-points in Patients With Primary Sjögren's SyndromeRecruitingNCT05113004Phase 2
- Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast CancerRecruitingNCT04997993Phase 1
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
- Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaRecruitingNCT04508790Phase 2
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingNCT03414502Phase 3
- Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent MalignancyCompletedNCT04532372Phase 1/2Results posted
- Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative DisordersCompletedNCT04463615Phase 2Results posted
- Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate MonotherapyTerminatedNCT02930343Phase 3Results posted
- Leflunomide in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT02509052Phase 1/2Results posted
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedNCT02451748Phase 4Results posted
- Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.CompletedNCT01172639Phase 4Results posted
- Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00834418Phase 1Results posted
- Leflunomide 20 mg Tablets, Non-FastingCompletedNCT00834405Phase 1Results posted
- Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid ArthritisCompletedNCT00579878Phase 3Results posted
- Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific RegionCompletedNCT00422227Phase 4Results posted
- Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular Juvenile Idiopathic Arthritis PatientsCompletedNCT07428551Phase 4
- Leflunomide Treatment for MEN1 Patients - the LUMEN1 TrialTerminatedNCT05605587Not applicable
- Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American PatientsActive, not recruitingNCT05014646Phase 2
- Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus DiseaseCompletedNCT05007678Phase 3
- Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell TransplantTerminatedNCT04932564Phase 2
- Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated VasculitisStatus unknownNCT04737343Not applicable
- Leflunomide for the Treatment of High-Risk Smoldering Multiple MyelomaActive, not recruitingNCT04370483Early Phase 1
- Leflunomide in Mild COVID-19 PatientsTerminatedNCT04361214Phase 1
- Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host DiseaseActive, not recruitingNCT04212416Phase 1
- Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal InsufficiencyStatus unknownNCT04020328Phase 4
- Leflunomide in Treating Patients With High-Risk Smoldering Multiple MyelomaWithdrawnNCT03952832Phase 2
- Leflunomide Treatment for IgG4-RDStatus unknownNCT03715699Not applicable
- Leflunomide in Previously Treated Metastatic Triple Negative CancersCompletedNCT03709446Phase 1/2
- Treatment With Leflunomide in Patients With Polymyalgia RheumaticaStatus unknownNCT03576794Phase 3
- Takayasu Arteritis Clinical Trial in ChinaCompletedNCT02981979Not applicable
- Leflunomide for Maintenance of Remission in IgG4 Related DiseaseCompletedNCT02703194Phase 4
- Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid ArthritisCompletedNCT02644499Phase 4
- The Research of Standard Diagnosis and Treatment for HSPN in ChildrenStatus unknownNCT02532777Phase 2
- Efficacy Study of Leflunomide to Treat Juvenile Idiopathic ArthritisStatus unknownNCT02024334Phase 4
- The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand ThymectomyCompletedNCT01727193Phase 3
- Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging StudyTerminatedNCT01659242Phase 4
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK ViruriaTerminatedNCT01620268Phase 2
- Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy ResearchStatus unknownNCT01617590Not applicable
- Leflunomide+Vemurafenib in V600 Mutant Met. MelanomaTerminatedNCT01611675Phase 1
- Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus NephritisStatus unknownNCT01172002Not applicable
- To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00946686Phase 1
- Leflunomide Associated With Topical Corticosteroids for Bullous PemphigoidStatus unknownNCT00802243Phase 2
- BK Viremia After Renal TransplantationStatus unknownNCT00684372Not applicable
- Bioavailability Study of Leflunomide Tablets Under Fed ConditionsCompletedNCT00653003Phase 1
- Bioavailability Study of Leflunomide Tablets Under Fasting ConditionsCompletedNCT00652665Phase 1
- Leflunomide in Systemic Lupus ErythematosusCompletedNCT00637819Phase 2
- Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid ArthritisCompletedNCT00596206Phase 3
- Leflunomide + Methotrexate in Rheumatoid ArthritisCompletedNCT00563849Phase 4
- Objective Study in Rheumatoid ArthritisCompletedNCT00451971Phase 4
- Leflunomide in Rheumatoid ArthritisCompletedNCT00280644Phase 4
- Effect of Leflunomide on T Cell Proliferation in HIV-Infected PatientsCompletedNCT00101374Phase 1
- Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate CancerCompletedNCT00004071Phase 2/3
- Leflunomide in Treating Patients With Anaplastic Astrocytoma in First RelapseCompletedNCT00003775Phase 2
- Leflunomide to Treat UveitisCompletedNCT00001863Phase 2
- A Phase I Study of SU101 in Pediatric Patients With Refractory MalignancyCompletedNCT00001573Phase 1